TCR gene-engineered cell therapy for solid tumors
Author:
Publisher
Elsevier BV
Subject
Clinical Biochemistry,Oncology
Reference63 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J Clin,2021
2. Cancer immunotherapy using T-cell receptor engineered T cell;Liu;Annals of Blood,2020
3. T cell receptor gene therapy for cancer;Schmitt;Hum Gene Ther,2009
4. Transfer of specificity by murine alpha and beta T-cell receptor genes;Dembic;Nature,1986
5. Structure of the T-cell antigen receptor: evidence for two CD3 epsilon subunits in the T-cell receptor-CD3 complex;Blumberg;Proc Natl Acad Sci U S A,1990
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer;Nature Reviews Urology;2024-07-01
2. EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion;Journal for ImmunoTherapy of Cancer;2024-06
3. Structure-Based Rational and General Strategy for Stabilizing Single-Chain T-Cell Receptors to Enhance Affinity;Journal of Medicinal Chemistry;2024-04-25
4. Nanotechnology as an emerging option in cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024
5. Vector-Mediated Delivery of Human Major Histocompatibility Complex-I into Hepatocytes Enables Investigation of T Cell Receptor-Redirected Hepatitis B Virus-Specific T Cells in Mice, and in Macaque Cell Cultures;Human Gene Therapy;2023-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3